原著論文1
Yan Y, Tsukamoto O, Nakano A, et al.
Augmented AMPK activity inhibits cell migration by phosphorylating the novel substrate Pdlim5.
Nature Communications
, 6
, 6137-
(2015)
10.1038/ncomms7137.
原著論文2
Hayashi T, Asano Y, Shintani Y, et al.
Higd1a is a positive regulator of cytochrome c oxidase.
Proc Natl Acad Sci U S A.
, 112
(5)
, 1553-1558
(2015)
10.1073/pnas.1419767112.
原著論文3
Sumida T, Naito AT, Nomura S, et al.
Complement C1q-induced activation of β-catenin signalling causes hypertensive arterial remodelling.
Nature Communications
, 6
, 6241-
(2015)
10.1038/ncomms7241.
原著論文4
Hashimoto A, Naito AT, Lee JK, et al.
Generation of induced pluripotent stem cells from the patients with Duchenne muscular dystrophy and its induction to cardiomyocytes.
International Heart Journal
, 57
(1)
, 112-117
(2016)
10.1536/ihj.15-376.
原著論文5
Tobita T, Nomura S, Morita H, et al.
Identification of MYLK3 mutations in familial dilated cardiomyopathy.
Scientific Reports
, 7
, 17495-
(2017)
10.1038/s41598-017-17769-1.
原著論文6
Tobita T, Nomura S, Fujita T, et al.
Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling.
Scientific Reports
, 8
, 1998-
(2018)
10.1038/s41598-018-20114-9.
原著論文7
Sakai T, Naito AT, Kuramoto Y, et al.
Phenotypic Screening Using Patient-Derived Induced Pluripotent Stem Cells Identified Pyr3 as a Candidate Compound for the Treatment of Infantile Hypertrophic Cardiomyopathy.
International Heart Journal
, 59
(5)
, 1096-1105
(2018)
10.1536/ihj.17-730.
原著論文8
Kuramoto Y, Naito AT, Tojo H et al.
Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient.
Journal of Molecular and Cellular Cardiology
, 121
, 256-265
(2018)
10.1016/j.yjmcc.2018.07.246.
